Advertisement
Thursday, Oct 28, 2021
Outlook.com
Outlook.com

Donald Trump Warns Of 'Retaliation' If India Doesn't Allow Export Of Drugs To Treat Coronavirus

Last month, India imposed a ban on export on Hydroxychloroquine, on which Trump is now banking heavily in the treatment of COVID-19 patients.

Donald Trump Warns Of 'Retaliation' If India Doesn't Allow Export Of Drugs To Treat Coronavirus
Prime Minister Narendra Modi with US President Donald Trump at UN General Assembly, New York. | AP Photo
Donald Trump Warns Of 'Retaliation' If India Doesn't Allow Export Of Drugs To Treat Coronavirus
outlookindia.com
2020-04-07T12:09:45+05:30

US President Donald Trump has said there would be retaliation if India did not allow the export of Hydroxychloroquine tablets, used to treat Coronavirus, to the United States despite a request made to New Delhi over the subject.

Last week Trump said that he has sought help from Prime Minister Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.

“I would be surprised if he would, you know, because India does very well with the United States,” Trump told reporters during a press briefing at the White House on Monday.

Hydroxychloroquine tablet is used to prevent and treat malaria, lupus and rheumatoid arthritis, among other ailments.

Also Read: Quarantine Over, Is It Safe To Meet Family? To Test Or Not To Test For Coronaovirus Is The Question

The drug is seen as to offer a viable therapeutic solution to coronavirus that has so far taken the lives of more than 10,000 Americans and infected over 3.6 lakhs, just in a matter of weeks.

Last month, India imposed a ban on export on Hydroxychloroquine, on which Trump is now banking heavily in the treatment of COVID-19 patients.

India has received similar requests from several other countries including its immediate neighbours like Sri Lanka and Nepal. India has said that it is reviewing its export ban order.

Notably, India's decision to ban the exports of Hydroxychloroquine is driven by its desire to take stock of the domestic requirements and ensure that the country has enough in its kitty.

Reiterating that for many years, India has been taking advantage of the US on trade, Trump said that he would be surprised if New Delhi was to stop the export of Hydroxychloroquine to the US.

Also Read: Damage Caused By Coronavirus Not Limited To Our Bodies, For Panic Is Far More Dangerous

“So, I would be surprised if that were his decision. He'd have to tell me that. I spoke to him Sunday morning, called him, and I said we'd appreciate your allowing our supply to come out. If he doesn't allow it to come out, that would be okay, but, of course, there may be retaliation. Why wouldn't there be?” Trump said.

On Monday, a senior State Department official said that India has been a significant partner of the US in the pharmaceutical sector and it expects similar cooperation to continue between the economies.

“India has long been a significant partner of the United States and the pharmaceutical sector,” Alice G Wells, the Acting Assistant Secretary of State for South and Central Asia, told reporters during a press briefing.

Also Read: What India Could Have Done To Better Handle The Deadly Coronavirus

The Trump administration has already created a national strategic stockpile of 29 million doses of the malaria drug, anticipating that its test results on more than 1,500 COVID-19 patients in New York are yielding positive results.

Scientists have begun testing Hydroxychloroquine and chloroquine as candidates for potential COVID-19 treatments and the FDA last week issued an Emergency Use Authorization for the prescription of the drugs in certain circumstances.

In addition to New York, COVID-19 patients in several States are being treated with Hydroxychloroquine, including Michigan and Texas.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Exclusive | SC’s Pegasus Order Gives Tremendous Credibility To Investigative Journalism: Dushyant Dave

Exclusive | SC’s Pegasus Order Gives Tremendous Credibility To Investigative Journalism: Dushyant Dave

Senior Supreme Court lawyer and former president of the Supreme Court Bar Association Dushyant Dave spoke to Outlook about the SC order to set up an expert committee to look into the snooping scandal using Israeli firm NSO's spyware Pegasus.

Aryan Khan To Return Home Either 'Tomorrow Or Saturday', Says Mukul Rohatgi

Aryan Khan To Return Home Either 'Tomorrow Or Saturday', Says Mukul Rohatgi

Former Attorney General, Mukul Rohatgi, who represented Aryan Khan in the Bombay High Court has said that that Aryan Khan will walk out of jail after the detailed order is given by the HC on Friday afternoon.

T20 World Cup, LIVE: Finch Departs After Giving Australia A Flying Start

T20 World Cup, LIVE: Finch Departs After Giving Australia A Flying Start

Follow live cricket scores of Australia vs Sri Lanka, T20 World Cup, Super 12 match in Dubai. Both teams have won their first matches.

J&K Administration Transfers Land To CRPF, Police In Kashmir

J&K Administration Transfers Land To CRPF, Police In Kashmir

The majority of the land in Kashmir has been allotted to CRPF in various south Kashmir districts, including picturesque Pahalgam tourist resort.

Advertisement